Capstone Financial Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,674
Closed -$266K 114
2019
Q3
$266K Hold
2,674
0.04% 71
2019
Q2
$247K Hold
2,674
0.04% 75
2019
Q1
$252K Buy
+2,674
New +$234K 0.04% 76
2018
Q4
Sell
-2,674
Closed -$239K 108
2018
Q3
$239K Hold
2,674
0.06% 68
2018
Q2
$212K Hold
2,674
0.06% 72
2018
Q1
$239K Buy
+2,674
New +$257K 0.08% 68
2015
Q2
Sell
-2,262
Closed -$261K 113
2015
Q1
$261K Sell
2,262
-63
-3% -$7.53K 0.1% 64
2014
Q4
$260K Sell
2,325
-803
-26% -$84.7K 0.08% 64
2014
Q3
$296K Buy
3,128
+570
+22% +$51.4K 0.18% 41
2014
Q2
$220K Sell
2,558
-770
-23% -$58.6K 0.15% 50
2014
Q1
$232K Buy
3,328
+888
+36% +$70.3K 0.14% 47
2013
Q4
$206K Buy
+2,440
New +$193K 0.13% 50

Other funds holding CELG

Capstone Financial Advisors's CELG Position: Q4 2019 in Review

Capstone Financial Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,674 shares — an estimated $266K sold.

Capstone Financial Advisors first reported a position in CELG in Q4 2013 and held it in 12 quarters. The position peaked at $296K in Q3 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Capstone Financial Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Capstone Financial Advisors sold 2,674 Celgene Corp shares in Q4 2019, an estimated $266K.
  • Capstone Financial Advisors first reported a position in Celgene Corp in Q4 2013 and held it in 12 quarters.
  • Capstone Financial Advisors's Celgene Corp position peaked at $296K in Q3 2014.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Capstone Financial Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.